Grant: LOVELACE BIOMEDICAL & ENVIRONMENTAL RESEARCH INSTITUTE INC
Primary Recipient
LOVELACE BIOMEDICAL & ENVIRONMENTAL RESEARCH INSTITUTE INC
Amount
$325,042.00
Award Date
7/15/2009
Administering Agency
Health and Human Services, Department of / National Institutes of Health
CDFA Number
93.701
CDFA Program Title
Trans-NIH Recovery Act Research Support
Description
The broad long-term objectives of the application are to determine the mechanisms by which the Severe Acute Respiratory Syndrome (SARS)-associated coronavirus (SCoV) causes acute lung injury and to identify new therapeutic strategies. The central hypothes
Vendors Connected to Award
| Vendor | Role | Amount |
|---|---|---|
| Burgoon Company | Primary vendor | $2,400.57 |
| VRW International | Primary vendor | $0.00 |
| USA Scientific | Primary vendor | $0.00 |
| BIO-RAD LABORATORIES, INC | Primary vendor | $0.00 |
| BIO EXPRESS | Primary vendor | $0.00 |
| EMD CHEMICALS | Primary vendor | $0.00 |
| Applied Biosystems | Primary vendor | $0.00 |
| Sigma Chemical/Aldrich | Primary vendor | $2,432.67 |
| Princeton Separations | Primary vendor | $1,111.00 |
| Laboratory Project Sales | Primary vendor | $0.00 |
| Gilson, Inc | Primary vendor | $0.00 |
| Sisher Scientific Co | Primary vendor | $1,407.53 |